Frank Bedu-Addo
President/CEO · PDS Biotechnology Corp
Individual
- 2025
- Mar 3, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Frank Bedu-Addo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $232.77M in AVAH purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Frank Bedu-Addo?
Frank Bedu-Addo is a corporate insider, tracked as President/CEO of PDS Biotechnology Corp (PDSB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Frank Bedu-Addo last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 2 filings going back to 2025.